|
US8563522B2
(en)
|
1997-07-08 |
2013-10-22 |
The Iams Company |
Method of maintaining and/or attenuating a decline in quality of life
|
|
US7381413B1
(en)
*
|
1998-04-17 |
2008-06-03 |
University Of Vermont And State Agricultural College |
Methods and products related to metabolic interactions in disease
|
|
EP1205493A1
(en)
*
|
2000-11-14 |
2002-05-15 |
ATOFINA Research |
Polymerisation catalyst systems and their preparation
|
|
US7666459B2
(en)
*
|
2001-09-12 |
2010-02-23 |
The Procter & Gamble Company |
Pet food compositions
|
|
US7547673B2
(en)
*
|
2001-09-13 |
2009-06-16 |
The Johns Hopkins University |
Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of ATP production
|
|
EP1599196A4
(en)
*
|
2003-01-17 |
2006-05-31 |
Threshold Pharmaceuticals Inc |
COMBINATION THERAPIES FOR CANCER TREATMENT
|
|
US20050158294A1
(en)
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
|
US8877178B2
(en)
|
2003-12-19 |
2014-11-04 |
The Iams Company |
Methods of use of probiotic bifidobacteria for companion animals
|
|
US7510710B2
(en)
*
|
2004-01-08 |
2009-03-31 |
The Regents Of The University Of Colorado |
Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor
|
|
JP5235304B2
(ja)
*
|
2004-02-06 |
2013-07-10 |
スレショルド ファーマシューティカルズ インコーポレイティッド |
抗癌療法
|
|
US20090252834A1
(en)
*
|
2004-05-10 |
2009-10-08 |
Michael Griffin Hayek |
Compositions comprising glucose anti-metabolites
|
|
EP1885379B1
(en)
|
2004-06-17 |
2016-07-20 |
Wisconsin Alumni Research Foundation |
Compounds and methods for treating seizure and paroxysmal disorders
|
|
US20070292478A1
(en)
*
|
2004-08-30 |
2007-12-20 |
Popowski Youri |
Medical Implant Provided with Inhibitors of Atp Synthesis
|
|
US20060078580A1
(en)
*
|
2004-10-08 |
2006-04-13 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
|
US7740875B2
(en)
*
|
2004-10-08 |
2010-06-22 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
|
MX2007004893A
(es)
*
|
2004-11-02 |
2007-06-14 |
Conforma Therapeutics Corp |
Metodos y composiciones para el tratamiento de leucemia linfocitica cronica.
|
|
SG166775A1
(en)
|
2005-02-18 |
2010-12-29 |
Abraxis Bioscience Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
US8735394B2
(en)
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
WO2006091790A1
(en)
|
2005-02-23 |
2006-08-31 |
Xenoport, Inc. |
Platinum-containing compounds exhibiting cytostatic activity, synthesis and methods of use
|
|
WO2006108680A2
(en)
|
2005-04-15 |
2006-10-19 |
Biomac Privatinstitut Für Medizinische Und Zahnmedizinische Forschung, Entwicklung Und Diagnostik Gmbh |
Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use against protozoa and helminthes
|
|
BRPI0611492B1
(pt)
|
2005-05-31 |
2021-10-13 |
Mars, Incorporated |
Bifidobactéria probiótica felina
|
|
JP4938005B2
(ja)
|
2005-05-31 |
2012-05-23 |
ザ・アイムス・カンパニー |
ネコ科動物プロバイオティックであるラクトバシラス
|
|
US20060287253A1
(en)
*
|
2005-06-17 |
2006-12-21 |
Kriegler Steven M |
Compounds and methods for treating seizure disorders
|
|
WO2006137595A1
(ja)
*
|
2005-06-24 |
2006-12-28 |
Takeda Pharmaceutical Company Limited |
Ｈｅｒ２発現癌の予防・治療薬
|
|
US20070032383A1
(en)
*
|
2005-07-27 |
2007-02-08 |
Newell M K |
Systems, methods, and compositions for modifying the metabolism of plants and of euucaryotic microbes
|
|
WO2007035755A2
(en)
*
|
2005-09-19 |
2007-03-29 |
Duke University |
Methods of treating hematological malignancies
|
|
ATE485037T1
(de)
|
2005-11-28 |
2010-11-15 |
Univ Ramot |
Krebsbehandlung mittels fts und 2-deoxyglucose
|
|
WO2007067516A2
(en)
*
|
2005-12-06 |
2007-06-14 |
Duke University |
Multiple myeloma
|
|
US7754693B2
(en)
*
|
2006-02-16 |
2010-07-13 |
Young Hee Ko |
Composition and method for the efficacious and safe administration of halopyruvate for the treatment of cancer
|
|
US8324175B2
(en)
*
|
2006-02-16 |
2012-12-04 |
Young Hee Ko |
Compositions and methods for the treatment of cancer
|
|
BRPI0708273A2
(pt)
*
|
2006-02-24 |
2011-05-24 |
Univ Texas |
uso de compostos de hexoses
|
|
EP1991056A4
(en)
*
|
2006-02-24 |
2009-09-02 |
Univ Miami |
MANNOSEDERIVATES FOR THE KILLING OF TUMOR CELLS
|
|
US9149489B2
(en)
*
|
2006-04-27 |
2015-10-06 |
Board Of Regents, University Of Texas System |
Inhibitors of glycolysis useful in the treatment of brain tumors
|
|
WO2009108926A1
(en)
*
|
2008-02-29 |
2009-09-03 |
Board Of Regents, The University Of Texas System |
Inhibitors of glycolysis useful in the treatment of brain tumors
|
|
US20090156660A1
(en)
*
|
2006-05-03 |
2009-06-18 |
Michal Svoboda |
Pharmaceutical composition containing taxane derivative destined for the preparation of an infusion solution, method of preparation thereof and use thereof
|
|
US8389248B2
(en)
|
2006-11-20 |
2013-03-05 |
National University Corporation Kagawa University |
Deoxyketohexose isomerase and method for producing deoxyhexose and derivative thereof using same
|
|
EP2114413B1
(en)
*
|
2006-12-18 |
2014-10-22 |
The Johns Hopkins University |
Therapeutics for treating cancer using 3-bromopyruvate
|
|
CA2673465A1
(en)
|
2007-02-01 |
2008-08-07 |
The Iams Company |
Method for decreasing inflammation and stress in a mammal
|
|
EP2156188B1
(en)
|
2007-03-28 |
2021-05-05 |
University of Southern California |
Induction of differential stress resistance and uses thereof
|
|
US8865646B2
(en)
*
|
2007-03-28 |
2014-10-21 |
University Of South California |
Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
|
|
RU2349271C2
(ru)
*
|
2007-03-29 |
2009-03-20 |
ФГУ Ростовский научно-исследовательский онкологический институт Росздрава |
Способ лечения рака прямой кишки
|
|
US8642067B2
(en)
|
2007-04-02 |
2014-02-04 |
Allergen, Inc. |
Methods and compositions for intraocular administration to treat ocular conditions
|
|
US8765690B2
(en)
*
|
2007-04-05 |
2014-07-01 |
Threshold Pharmaceuticals, Inc. |
Treatment of cancer with glufosfamide in patients not receiving insulin therapy
|
|
WO2009102986A1
(en)
*
|
2008-02-15 |
2009-08-20 |
Catholic Healthcare West (D/B/A St. Joseph's Hospital And Medical Center) |
Treatment of adenocarcinoma expressing lkb1 with mtor inhibitor in combination with cox1 inhibitor
|
|
WO2009105230A2
(en)
|
2008-02-21 |
2009-08-27 |
The Regents Of The University Of Colorado |
Methods for treating cancer using combination therapy
|
|
CN102076865B
(zh)
|
2008-05-02 |
2016-03-16 |
西雅图基因公司 |
用于制造核心岩藻糖基化降低的抗体和抗体衍生物的方法和组合物
|
|
EP2303282A4
(en)
*
|
2008-05-23 |
2013-02-13 |
Univ Miami |
TREATMENT WITH CONTINUOUS LOW DOSED APPLICATION OF SUGAR ANALOGUE
|
|
CA2723587C
(en)
*
|
2008-05-27 |
2017-09-26 |
Oncolytics Biotech Inc. |
Abrogating proinflammatory cytokine production during oncolytic reovirus therapy
|
|
US9771199B2
(en)
|
2008-07-07 |
2017-09-26 |
Mars, Incorporated |
Probiotic supplement, process for making, and packaging
|
|
HUE033210T2
(hu)
*
|
2008-07-11 |
2017-11-28 |
Univ Texas |
Rákellenes aktivitású 2-dezoxi-monoszacharidok új acetátjai
|
|
US9073985B2
(en)
|
2008-07-14 |
2015-07-07 |
The Regents Of The University Of Colorado, A Body Corporate |
Methods and products for treating proliferative diseases
|
|
WO2010019396A1
(en)
*
|
2008-08-13 |
2010-02-18 |
Threshold Pharmaceuticals, Inc. |
Administration of glufosfamide for the treatment of cancer
|
|
EP2331092B1
(en)
*
|
2008-08-21 |
2014-03-19 |
The Johns Hopkins University |
Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer
|
|
UA104147C2
(uk)
*
|
2008-09-10 |
2014-01-10 |
Новартис Аг |
Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань
|
|
SI2391363T1
(sl)
*
|
2009-01-29 |
2017-01-31 |
Young Hee Ko |
Sestavki in postopki za zdravljenje raka
|
|
EP2406389B1
(en)
|
2009-03-13 |
2019-05-08 |
Agios Pharmaceuticals, Inc. |
Methods and compositions for cell-proliferation-related disorders
|
|
CA2944788C
(en)
|
2009-06-29 |
2023-08-22 |
Agios Pharmaceuticals, Inc. |
Compounds, and compositions thereof, which modulate pyruvate kinase m2, and methods of making same
|
|
US10104903B2
(en)
|
2009-07-31 |
2018-10-23 |
Mars, Incorporated |
Animal food and its appearance
|
|
US8450090B2
(en)
|
2009-10-06 |
2013-05-28 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions and methods for promoting fatty acid production in plants
|
|
CA2793835C
(en)
|
2009-10-21 |
2021-07-20 |
Agios Pharmaceuticals, Inc. |
Methods and compositions for cell-proliferation-related disorders
|
|
WO2011050211A2
(en)
|
2009-10-21 |
2011-04-28 |
Agios Pharmaceuticals, Inc. |
Methods and compositions for cell-proliferation-related disorders
|
|
RU2012120785A
(ru)
*
|
2009-10-22 |
2013-11-27 |
ПРОПАНК ПиТиУай ЛТД |
Фармацевтические композиции
|
|
CN102115483B
(zh)
|
2009-12-30 |
2014-12-17 |
苏州天人合生物技术有限公司 |
卤代双去氧糖衍生物及其制备方法与应用
|
|
GB2478556A
(en)
*
|
2010-03-09 |
2011-09-14 |
Myrovlytis Technology Ventures Ltd |
A composition for use in the treatment of Birt-Hogg-Dubô sydrome
|
|
KR101894689B1
(ko)
|
2010-03-29 |
2018-09-04 |
아브락시스 바이오사이언스, 엘엘씨 |
암의 치료 방법
|
|
CA2794147A1
(en)
|
2010-03-29 |
2011-10-06 |
Abraxis Bioscience, Llc |
Use of a composition comprising nanoparticles comprising a taxane and an albumin to improve uptake of chemotherapeutics by tumors and for treating a cancer that is highly fibrotic and/or has a dense stroma
|
|
EP2575804A4
(en)
|
2010-06-04 |
2013-10-23 |
Abraxis Bioscience Llc |
METHOD FOR THE TREATMENT OF PANCREASCRE
|
|
WO2012019165A2
(en)
|
2010-08-05 |
2012-02-09 |
Seattle Genetics, Inc. |
Methods of inhibition of protein fucosylation in vivo using fucose analogs
|
|
EP2627321A1
(en)
|
2010-10-13 |
2013-08-21 |
Mustafa Bilgin Ali Djamgoz |
Treatment of cancer/inhibition of metastasis
|
|
WO2012049439A1
(en)
*
|
2010-10-13 |
2012-04-19 |
Imperial Innovations Limited |
Treatment of cancer/inhibition of metastasis
|
|
WO2012097052A2
(en)
*
|
2011-01-11 |
2012-07-19 |
Intertech Bio, Llc |
Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseases
|
|
WO2012123774A1
(en)
*
|
2011-03-11 |
2012-09-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Glycolytic inhibitor with cytotoxic agent for use in the treatment of a cancer
|
|
US20120238511A1
(en)
*
|
2011-03-14 |
2012-09-20 |
University Of Southern California |
2-deoxy-d-glucose formulations for prevention or treatment of neurodegenerative diseases
|
|
KR101873543B1
(ko)
|
2011-05-03 |
2018-07-02 |
아지오스 파마슈티컬스 아이엔씨. |
치료에 사용하기 위한 피루베이트 키나아제 활성제
|
|
CN102827073A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
|
CN102827170A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
|
EP2739971A1
(en)
*
|
2011-08-02 |
2014-06-11 |
Roche Diagnostics GmbH |
In vitro tumor metastasis model
|
|
KR101900478B1
(ko)
*
|
2011-08-04 |
2018-09-20 |
한올바이오파마주식회사 |
암의 재발 또는 전이의 억제용 약제학적 조성물
|
|
SG11201403878QA
(en)
|
2012-01-06 |
2014-08-28 |
Agios Pharmaceuticals Inc |
Therapeutically active compounds and their methods of use
|
|
US9474779B2
(en)
|
2012-01-19 |
2016-10-25 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compositions and their methods of use
|
|
US20160015725A1
(en)
*
|
2012-02-14 |
2016-01-21 |
The Wistar Institute Of Anatomy And Biology |
Methods of controlling tumor bioenergetics networks
|
|
AU2013202693B2
(en)
*
|
2012-04-16 |
2015-01-22 |
Baxalta GmbH |
Combination Therapy of Anti-MIF Antibodies and Chemotherapeutics
|
|
CA2882725C
(en)
|
2012-08-23 |
2021-03-09 |
Regents Of The University Of Minnesota |
Treatment of sickle cell disease and inflammatory conditions
|
|
HK1213798A1
(zh)
|
2012-10-15 |
2016-07-15 |
安吉奥斯医药品有限公司 |
治療性化合物和組合物
|
|
WO2014072967A1
(en)
*
|
2012-11-12 |
2014-05-15 |
Urifer Ltd |
Drug combination comprising a glycolysis inhibitor and a tyrosine kinase inhibitor
|
|
KR101419816B1
(ko)
*
|
2013-01-30 |
2014-07-17 |
(주)제욱 |
상승적 치료 효과를 갖는 비소세포폐암의 예방 또는 치료용 조성물
|
|
EP3939595A1
(en)
|
2013-04-05 |
2022-01-19 |
Board of Regents, The University of Texas System |
Esters of 2-deoxy-monosaccharides with anti proliferative activity
|
|
WO2015003360A2
(en)
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
|
CA2917671A1
(en)
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
2,4-or 4,6-diaminopyrimidine compounds as idh2 mutants inhibitors for the treatment of cancer
|
|
WO2015003355A2
(en)
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
|
US9579324B2
(en)
|
2013-07-11 |
2017-02-28 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
|
US20150031627A1
(en)
|
2013-07-25 |
2015-01-29 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
|
AU2015206629B2
(en)
|
2014-01-14 |
2020-03-05 |
The Johns Hopkins University |
Cyclodextrin compositions encapsulating a selective ATP inhibitor and uses thereof
|
|
CA2942072C
(en)
|
2014-03-14 |
2022-07-26 |
Agios Pharmaceuticals, Inc. |
Pharmaceutical compositions and use of (s)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-( 4-cyanopyridin-2-yl)-n-( 5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide
|
|
WO2016065353A1
(en)
*
|
2014-10-24 |
2016-04-28 |
University Of Miami |
Combination therapy with fenofibrate and 2-deoxyglucose or 2-deoxymannose
|
|
DK3307271T3
(da)
|
2015-06-11 |
2023-10-09 |
Agios Pharmaceuticals Inc |
Fremgangsmåder til anvendelse af pyruvatkinase-aktivatorer
|
|
MA71411A
(fr)
|
2015-10-15 |
2025-04-30 |
Les Laboratoires Servier |
Polythérapie pour le traitement de tumeurs malignes
|
|
DK3362066T3
(da)
|
2015-10-15 |
2021-11-22 |
Les Laboratoires Servier Sas |
Kombinationsterapi til behandling af maligniteter
|
|
EP3370712B1
(en)
|
2015-11-06 |
2025-02-19 |
The Johns Hopkins University |
3-bromopyruvate for treating liver fibrosis
|
|
HK1259489A1
(zh)
|
2015-11-12 |
2019-11-29 |
普罗潘克股份有限公司 |
酶原组合物
|
|
JP7058604B2
(ja)
|
2016-01-29 |
2022-04-22 |
プロパンク・ピーティーワイ・リミテッド |
癌治療
|
|
WO2017173360A2
(en)
*
|
2016-03-31 |
2017-10-05 |
Stcube, Inc. |
Combination treatments directed toward programmed death ligand-1 (pd-l1) positive cancers
|
|
KR20200018634A
(ko)
|
2017-06-28 |
2020-02-19 |
가부시키가이샤 센탄이료카이하츠 |
의약조성물 및 종양면역활성 촉진제
|
|
EP3654963A4
(en)
|
2017-07-21 |
2021-04-14 |
Buck Institute for Research on Aging |
BETA-HYDROXYBUTYRATE AND BUTANEDIOL S ENANTIOMERS AND THEIR METHODS OF USE
|
|
WO2019147503A1
(en)
|
2018-01-25 |
2019-08-01 |
Buck Institute For Research On Aging |
Synthesis of 3-hydroxybutyryl 3-hydroxybutyrate and related compounds
|
|
US11013733B2
(en)
|
2018-05-16 |
2021-05-25 |
Forma Therapeutics, Inc. |
Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1)
|
|
US11311527B2
(en)
|
2018-05-16 |
2022-04-26 |
Forma Therapeutics, Inc. |
Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)
|
|
US11013734B2
(en)
|
2018-05-16 |
2021-05-25 |
Forma Therapeutics, Inc. |
Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutation
|
|
EP3720442B1
(en)
|
2018-05-16 |
2022-12-28 |
Forma Therapeutics, Inc. |
Inhibiting mutant idh-1
|
|
US10532047B2
(en)
|
2018-05-16 |
2020-01-14 |
Forma Therapeutics, Inc. |
Solid forms of ((S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile
|
|
US10980788B2
(en)
|
2018-06-08 |
2021-04-20 |
Agios Pharmaceuticals, Inc. |
Therapy for treating malignancies
|
|
RU2707554C1
(ru)
*
|
2019-02-27 |
2019-11-28 |
Федеральное государственное бюджетное учреждение "Петербургский институт ядерной физики им. Б.П. Константинова Национального исследовательского центра "Курчатовский институт" (НИЦ "Курчатовский институт-ПИЯФ") |
Композиция, ингибирующая рост и выживаемость опухолевых клеток
|
|
MX2022011488A
(es)
|
2020-03-16 |
2023-03-01 |
Univ Texas |
Método para tratar infecciones virales con monosacáridos tipo hexosa y análogos de los mismos.
|
|
US20230092706A1
(en)
*
|
2020-04-16 |
2023-03-23 |
Buck Institute For Research On Aging |
Treatment of viral pathologies with exogenous ketones
|
|
EP4259190A1
(en)
*
|
2020-12-14 |
2023-10-18 |
Trim Biotech, S.L. |
Compositions comprising bacteria for cancer immunotherapy
|
|
WO2023062516A1
(en)
*
|
2021-10-11 |
2023-04-20 |
Exploration Invest Pte Ltd |
2-deoxy-d-glucose for use in disease therapy
|
|
CN114617876B
(zh)
*
|
2022-01-28 |
2023-04-07 |
四川大学华西医院 |
一种抗肿瘤联合用药物
|
|
KR20240038394A
(ko)
|
2022-09-16 |
2024-03-25 |
이화여자대학교 산학협력단 |
해당과정 억제제 및 미토콘드리아 기능 억제제를 포함하는 암의 예방 또는 치료용 약학적 조성물
|
|
EP4582080A1
(en)
|
2024-01-02 |
2025-07-09 |
G.ST Antivirals GmbH |
Dispenser for mucosal administration comprising 2-deoxy-glucose or analogues thereof
|